enGene Holdings Inc.

NASDAQ:ENGN

Biotechnology

Healthcare
$1.72 -1.15%

-$0.02 today

Market cap
$115.27M
Beta
-0.29
P/E (TTM)
-1.8
EPS (TTM)
-$0.95
52W Low $1.40High $12.25

Volume 1.64M

Average 1.58M

Returns on capital

enGene Holdings Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-69.9%

avg -44.3%

ROIC

-61.7%

avg -23.5%

ROA

-53.0%

avg -37.0%

Analysis

ROA is currently the strongest return metric at -53.0% versus its period average of -37.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Ronald H. W. Cooper

President, Chief Executive Officer & DirectorUSD 1.21M63——

Anthony T. Cheung

ConsultantUSD 341.75K54——

William J. Grossman

Interim Chief Medical Officer & DirectorUSD 15.99K56——

Matthew Boyd

Chief Regulatory Officer—52——

Amy Pott

Chief Global Commercialization Officer—50400.00K0.78%

Jill Buck

Chief Development Officer—52195.00K0.38%

Joan Connolly

Chief Technology Officer—56195.00K0.38%

Kathleen Richton

Senior VP of Finance, Principal Accounting & Financial Officer and Controller—48——

Tara Place

Senior Vice President of Human Resources————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jan 30, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

1

$10,050.94

Sells

0

$0.00

Net Transaction Value

+$10,050.94

Net buying

Most Active

Grossman William

1 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Sep 22, 26

Grossman William

Direct

Buy$10.1K

Summary

Insiders reported 1 buys worth $10,050.94 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $10,050.94. Grossman William was the most active insider with 1 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A2 analysts
RevenueN/AN/AN/A
N/A2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does enGene Holdings Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about ENGN's management, answered from reported figures.

Who manages ENGN?

enGene Holdings Inc. (ENGN) lists 9 active executives. The top listed executive is Anthony T. Cheung, Consultant.

Are ENGN insiders buying or selling?

Recent insider activity shows net buying of $109.93M.